[DOI] [PubMed] [Google Scholar] [158].Fineman MS, Mace KF, Diamant M, Darsow T, Cirincione BB, Booker Porter TK, Kinninger LA, Trautmann ME, Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment, Diabetes, obesity & metabolism, 14 (2012) 546554
Youssef NA, Shaban SA, Ibrahim FA, Mahmoud AS (2016) Degradation of Methyl orange using Fenton catalytic reaction
2,11 But if a patient cannot tolerate escalation and is benefiting at a low dose, I would rather keep her on a tolerable dose than lose her from treatment altogether
Sayeds office for a consultation
Shift Towards Targeted, Multi-Benefit Medications: GLP-1 receptor agonists not only help regulate blood sugar but also promote weight loss, offering patients additional benefits beyond traditional diabetes medications